Oxford Immunotec
Oxford Immunotec Signs up Green Cross Medical Science to Market T-Cell SARS-CoV-2 Kit in South Korea
Oxford Immunotec's T-SPOT Discovery SARS-CoV-2 kit adds a research test for measuring the T cell response to SARS-CoV-2 infection to GCMS' portfolio.
PerkinElmer to Buy Oxford Immunotec for $591M
The deal will enable PerkinElmer to grow its infectious disease testing portfolio to include latent tuberculosis detection, it said.
UK researchers said they are developing a commercial test that could enable sensitive detection of tuberculosis DNA in blood and provide an option to broaden screening.